Notify me when Integral Health Asset Management, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 84 | $1,973,148,980 | +$725,349,650 | -$325,640,850 | +$399,708,800 | INSM, RVMD, VERA, CYTK, REGN | 13F-HR | 17 Feb 2026, 10:17 |
| Q3 2025 | 72 | $1,371,854,770 | +$311,513,500 | -$305,018,150 | +$6,495,350 | INSM, CYTK, THC, MLYS, VERA | 13F-HR | 14 Nov 2025, 08:39 |
| Q2 2025 | 70 | $1,070,468,420 | +$300,901,100 | -$195,156,730 | +$105,744,370 | INSM, BSX, THC, EHC, MLYS | 13F-HR | 14 Aug 2025, 08:17 |
| Q1 2025 | 76 | $902,672,100 | +$287,036,160 | -$475,669,770 | -$188,633,610 | INSM, BSX, CYTK, THC, MLYS | 13F-HR | 15 May 2025, 07:01 |
| Q4 2024 | 81 | $1,130,713,250 | +$515,791,840 | -$194,317,700 | +$321,474,140 | INSM, THC, BSX, VERA, CYTK | 13F-HR | 14 Feb 2025, 09:41 |
| Q3 2024 | 63 | $849,374,310 | +$221,256,710 | -$430,889,350 | -$209,632,640 | INSM, THC, BSX, CYTK, LBPH | 13F-HR | 14 Nov 2024, 11:30 |
| Q2 2024 | 69 | $1,004,697,900 | +$320,079,550 | -$344,401,360 | -$24,321,810 | INSM, THC, CYTK, BSX, ELV | 13F-HR | 14 Aug 2024, 08:04 |
| Q1 2024 | 76 | $1,018,719,770 | +$446,304,420 | -$222,741,960 | +$223,562,460 | THC, BSX, VKTX, INSM, CYTK | 13F-HR | 15 May 2024, 11:14 |
| Q4 2023 | 67 | $692,524,370 | +$346,390,000 | -$437,791,240 | -$91,401,240 | WBA, THC, ABBV, NVS, REGN | 13F-HR | 14 Feb 2024, 10:28 |
| Q3 2023 | 62 | $704,628,540 | +$318,144,020 | -$321,502,630 | -$3,358,610 | THC, ARGX, BSX, MLTX, CYTK | 13F-HR | 14 Nov 2023, 08:57 |
| Q2 2023 | 70 | $762,015,550 | +$450,336,669 | -$197,508,510 | +$252,828,159 | CI, ZBH, INSP, MCK, BSX | 13F-HR | 11 Aug 2023, 10:55 |
| Q1 2023 | 67 | $481,299,825 | +$224,513,095 | -$187,400,000 | +$37,113,095 | ELV, CYTK, INSP, COO, SYK | 13F-HR | 09 May 2023, 12:47 |
| Q4 2022 | 59 | $443,590,640 | +$227,582,115 | -$278,084,970 | -$50,502,855 | CYTK, MRNA, BMRN, MRK, DGX | 13F-HR | 13 Feb 2023, 10:53 |
| Q3 2022 | 64 | $489,364,000 | +$196,685,889 | -$210,948,273 | -$14,262,384 | GH, ELV, CNC, CYTK, BAX | 13F-HR | 14 Nov 2022, 10:55 |
| Q2 2022 | 65 | $486,158,000 | +$240,193,981 | -$98,621,709 | +$141,572,272 | ELV, CNC, LLY, CYTK, SNY | 13F-HR | 03 Aug 2022, 14:13 |
| Q1 2022 | 71 | $384,302,000 | +$157,905,137 | -$102,517,154 | +$55,387,983 | ELV, CYTK, PFE, GMED, RVTY | 13F-HR | 12 May 2022, 16:26 |
| Q4 2021 | 70 | $358,880,000 | +$139,166,154 | -$142,494,946 | -$3,328,792 | CNC, SAGE, CYTK, RVTY, MCK | 13F-HR | 02 Feb 2022, 10:17 |
| Q3 2021 | 70 | $347,863,000 | +$140,028,611 | -$149,906,431 | -$9,877,820 | ARNA, ACHC, SAGE, CVS, CYTK | 13F-HR | 12 Nov 2021, 10:26 |
| Q2 2021 | 71 | $363,239,000 | +$153,629,321 | -$160,715,658 | -$7,086,337 | ELV, ACHC, ARNA, CYTK, SAGE | Restatement | 30 Aug 2021, 12:05 |
| Q1 2021 | 69 | $349,991,000 | +$147,942,679 | -$129,952,021 | +$17,990,658 | ACHC, CYTK, ARNA, NVST, NTLA | 13F-HR | 10 May 2021, 09:54 |
| Q4 2020 | 57 | $336,207,000 | +$126,494,733 | -$149,232,391 | -$22,737,658 | SAGE, ACHC, ARNA, NVRO, LHCG | 13F-HR | 16 Feb 2021, 16:13 |
| Q3 2020 | 68 | $316,686,000 | +$123,101,686 | -$154,663,244 | -$31,561,558 | LHCG, SAGE, RVTY, ABT, ARNA | 13F-HR | 16 Nov 2020, 11:43 |
| Q2 2020 | 58 | $328,154,000 | +$160,231,846 | -$106,741,550 | +$53,490,296 | LHCG, DGX, BMY, ARNA, BMRN | 13F-HR | 14 Aug 2020, 09:30 |
| Q1 2020 | 51 | $227,032,000 | +$149,143,307 | -$158,549,706 | -$9,406,399 | MDT, CNC, MRK, BMY, DGX | 13F-HR | 15 May 2020, 13:24 |
| Q4 2019 | 50 | $256,814,000 | $0 | $0 | $0 | A, DXCM, BMY, MDT, AMED | 13F-HR | 13 Feb 2020, 11:21 |